biomarkers in nash drug development
Published 4 years ago • 301 plays • Length 1:01:13Download video MP4
Download video MP3
Similar videos
-
27:51
ck18 as a biomarker in nash clinical trials
-
38:02
nash globally: pathways to combination therapy, biomarkers and outcomes | arun sanyal
-
2:02:48
use of biomarkers for diagnosing and assessing treatment response in noncirrhotic nash trials-d1-pm
-
4:08:18
use of biomarkers for diagnosing and assessing treatment response in noncirrhotic nash trials-d1-am
-
2:26:33
use of biomarkers for diagnosing and assessing treatment response in noncirrhotic nash trials-d2-am
-
9:07
case study: discovery of an early diagnostic biomarker for nash
-
3:06
understanding nash (non-alcoholic steatohepatitis)
-
4:45
hope for patients with nash
-
15:13
immunity in crisis: how gut health fuels chronic disease
-
30:25
navigating nash biomarkers: from discovery to clinical practice | john sninsky, phd
-
4:22:45
use of biomarkers for diagnosing and assessing treatment response in noncirrhotic nash trials-d2-pm
-
1:26:03
regulatory perspectives for development of drugs for treatment of nash
-
10:02
leveraging pathophysiology and context of use to identify nash clinical trial biomarkers
-
48:30
clinical overview of nafl/nash
-
28:34
mre for nafld and nash clinical trials
-
18:03
nash update: nash drug development update
-
27:22
pathophysiology and treatment of nash - novel insights # prof. arun sanyal
-
13:02
collaboration in action - foundation for the national institutes of health | roberto calle
-
4:46
non-invasive biomarkers of metabolic liver disease (nimble)
-
1:03:15
a proteomics signature of nash
-
54:09
the dawn of translation in nash and hepatic fibrosis
-
4:48
dear scientist: nash